logo
Breadcrumbs Image

Prostate Cancer Medicine Market

Prostate Cancer Medicine Market

Global Prostate Cancer Medicine Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027


Date: Apr-2021 | Id: MACRC-63077 | Geographical Scope: Global | Publisher: Mnemonics Research

The global Prostate Cancer Medicine market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Rresearch newly published report.
 The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
 
 By Market Verdors:
 AstraZeneca plc
 Active Biotech
 Bristol Myers-Squibb
 Teva Pharmaceuticals Industries Ltd.
 Johnson & Johnson
 Pfizer Inc.
 Bayer AG
 Abbott Laboratories
 Astellas Pharma Inc.
 Roche Holding AG
 
 By Types:
 LHRH Antagonists
 LHRH Analogs
 Antiandrogens
 Pipeline Drugs for Hormonal Therapy
 
 By Applications:
 Hospitals
 Other
 
 Key Indicators Analysed
 Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
 Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
 Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
 Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
 Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
 
 Key Reasons to Purchase
 To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
 Assess the production processes, major issues, and solutions to mitigate the development risk.
 To understand the most affecting driving and restraining forces in the market and its impact in the global market.
 Learn about the market strategies that are being adopted by leading respective organizations.
 To understand the future outlook and prospects for the market.
 Besides the standard structure reports, we also provide custom research according to specific requirements.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
 1.1 Study Scope and Definition
 1.2 Research Methodology
 1.2.1 Methodology/Research Approach
 1.2.2 Data Source
 1.3 Key Market Segments
 1.4 Players Covered: Ranking by Prostate Cancer Medicine Revenue
 1.5 Market Analysis by Type
 1.5.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2021 VS 2027
 1.5.2 LHRH Antagonists
 1.5.3 LHRH Analogs
 1.5.4 Antiandrogens
 1.5.5 Pipeline Drugs for Hormonal Therapy
 1.6 Market by Application
 1.6.1 Global Prostate Cancer Medicine Market Share by Application: 2022-2027
 1.6.2 Hospitals
 1.6.3 Other
 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections
 1.7.2 Covid-19 Impact: Commodity Prices Indices
 1.7.3 Covid-19 Impact: Global Major Government Policy
 1.8 Study Objectives
 1.9 Years Considered
 2 Global Prostate Cancer Medicine Market Trends and Growth Strategy
 2.1 Market Top Trends
 2.2 Market Drivers
 2.3 Market Challenges
 2.4 Porter’s Five Forces Analysis
 2.5 Market Growth Strategy
 2.6 SWOT Analysis
 3 Global Prostate Cancer Medicine Market Players Profiles
 3.1 AstraZeneca plc
 3.1.1 AstraZeneca plc Company Profile
 3.1.2 AstraZeneca plc Prostate Cancer Medicine Product Specification
 3.1.3 AstraZeneca plc Prostate Cancer Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.2 Active Biotech
 3.2.1 Active Biotech Company Profile
 3.2.2 Active Biotech Prostate Cancer Medicine Product Specification
 3.2.3 Active Biotech Prostate Cancer Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.3 Bristol Myers-Squibb
 3.3.1 Bristol Myers-Squibb Company Profile
 3.3.2 Bristol Myers-Squibb Prostate Cancer Medicine Product Specification
 3.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.4 Teva Pharmaceuticals Industries Ltd.
 3.4.1 Teva Pharmaceuticals Industries Ltd. Company Profile
 3.4.2 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product Specification
 3.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.5 Johnson & Johnson
 3.5.1 Johnson & Johnson Company Profile
 3.5.2 Johnson & Johnson Prostate Cancer Medicine Product Specification
 3.5.3 Johnson & Johnson Prostate Cancer Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.6 Pfizer Inc.
 3.6.1 Pfizer Inc. Company Profile
 3.6.2 Pfizer Inc. Prostate Cancer Medicine Product Specification
 3.6.3 Pfizer Inc. Prostate Cancer Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.7 Bayer AG
 3.7.1 Bayer AG Company Profile
 3.7.2 Bayer AG Prostate Cancer Medicine Product Specification
 3.7.3 Bayer AG Prostate Cancer Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.8 Abbott Laboratories
 3.8.1 Abbott Laboratories Company Profile
 3.8.2 Abbott Laboratories Prostate Cancer Medicine Product Specification
 3.8.3 Abbott Laboratories Prostate Cancer Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.9 Astellas Pharma Inc.
 3.9.1 Astellas Pharma Inc. Company Profile
 3.9.2 Astellas Pharma Inc. Prostate Cancer Medicine Product Specification
 3.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 3.10 Roche Holding AG
 3.10.1 Roche Holding AG Company Profile
 3.10.2 Roche Holding AG Prostate Cancer Medicine Product Specification
 3.10.3 Roche Holding AG Prostate Cancer Medicine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
 4 Global Prostate Cancer Medicine Market Competition by Market Players
 4.1 Global Prostate Cancer Medicine Production Capacity Market Share by Market Players (2016-2021)
 4.2 Global Prostate Cancer Medicine Revenue Market Share by Market Players (2016-2021)
 4.3 Global Prostate Cancer Medicine Average Price by Market Players (2016-2021)
 5 Global Prostate Cancer Medicine Production by Regions (2016-2021)
 5.1 North America
 5.1.1 North America Prostate Cancer Medicine Market Size (2016-2021)
 5.1.2 Prostate Cancer Medicine Key Players in North America (2016-2021)
 5.1.3 North America Prostate Cancer Medicine Market Size by Type (2016-2021)
 5.1.4 North America Prostate Cancer Medicine Market Size by Application (2016-2021)
 5.2 East Asia
 5.2.1 East Asia Prostate Cancer Medicine Market Size (2016-2021)
 5.2.2 Prostate Cancer Medicine Key Players in East Asia (2016-2021)
 5.2.3 East Asia Prostate Cancer Medicine Market Size by Type (2016-2021)
 5.2.4 East Asia Prostate Cancer Medicine Market Size by Application (2016-2021)
 5.3 Europe
 5.3.1 Europe Prostate Cancer Medicine Market Size (2016-2021)
 5.3.2 Prostate Cancer Medicine Key Players in Europe (2016-2021)
 5.3.3 Europe Prostate Cancer Medicine Market Size by Type (2016-2021)
 5.3.4 Europe Prostate Cancer Medicine Market Size by Application (2016-2021)
 5.4 South Asia
 5.4.1 South Asia Prostate Cancer Medicine Market Size (2016-2021)
 5.4.2 Prostate Cancer Medicine Key Players in South Asia (2016-2021)
 5.4.3 South Asia Prostate Cancer Medicine Market Size by Type (2016-2021)
 5.4.4 South Asia Prostate Cancer Medicine Market Size by Application (2016-2021)
 5.5 Southeast Asia
 5.5.1 Southeast Asia Prostate Cancer Medicine Market Size (2016-2021)
 5.5.2 Prostate Cancer Medicine Key Players in Southeast Asia (2016-2021)
 5.5.3 Southeast Asia Prostate Cancer Medicine Market Size by Type (2016-2021)
 5.5.4 Southeast Asia Prostate Cancer Medicine Market Size by Application (2016-2021)
 5.6 Middle East
 5.6.1 Middle East Prostate Cancer Medicine Market Size (2016-2021)
 5.6.2 Prostate Cancer Medicine Key Players in Middle East (2016-2021)
 5.6.3 Middle East Prostate Cancer Medicine Market Size by Type (2016-2021)
 5.6.4 Middle East Prostate Cancer Medicine Market Size by Application (2016-2021)
 5.7 Africa
 5.7.1 Africa Prostate Cancer Medicine Market Size (2016-2021)
 5.7.2 Prostate Cancer Medicine Key Players in Africa (2016-2021)
 5.7.3 Africa Prostate Cancer Medicine Market Size by Type (2016-2021)
 5.7.4 Africa Prostate Cancer Medicine Market Size by Application (2016-2021)
 5.8 Oceania
 5.8.1 Oceania Prostate Cancer Medicine Market Size (2016-2021)
 5.8.2 Prostate Cancer Medicine Key Players in Oceania (2016-2021)
 5.8.3 Oceania Prostate Cancer Medicine Market Size by Type (2016-2021)
 5.8.4 Oceania Prostate Cancer Medicine Market Size by Application (2016-2021)
 5.9 South America
 5.9.1 South America Prostate Cancer Medicine Market Size (2016-2021)
 5.9.2 Prostate Cancer Medicine Key Players in South America (2016-2021)
 5.9.3 South America Prostate Cancer Medicine Market Size by Type (2016-2021)
 5.9.4 South America Prostate Cancer Medicine Market Size by Application (2016-2021)
 5.10 Rest of the World
 5.10.1 Rest of the World Prostate Cancer Medicine Market Size (2016-2021)
 5.10.2 Prostate Cancer Medicine Key Players in Rest of the World (2016-2021)
 5.10.3 Rest of the World Prostate Cancer Medicine Market Size by Type (2016-2021)
 5.10.4 Rest of the World Prostate Cancer Medicine Market Size by Application (2016-2021)
 6 Global Prostate Cancer Medicine Consumption by Region (2016-2021)
 6.1 North America
 6.1.1 North America Prostate Cancer Medicine Consumption by Countries
 6.1.2 United States
 6.1.3 Canada
 6.1.4 Mexico
 6.2 East Asia
 6.2.1 East Asia Prostate Cancer Medicine Consumption by Countries
 6.2.2 China
 6.2.3 Japan
 6.2.4 South Korea
 6.3 Europe
 6.3.1 Europe Prostate Cancer Medicine Consumption by Countries
 6.3.2 Germany
 6.3.3 United Kingdom
 6.3.4 France
 6.3.5 Italy
 6.3.6 Russia
 6.3.7 Spain
 6.3.8 Netherlands
 6.3.9 Switzerland
 6.3.10 Poland
 6.4 South Asia
 6.4.1 South Asia Prostate Cancer Medicine Consumption by Countries
 6.4.2 India
 6.5 Southeast Asia
 6.5.1 Southeast Asia Prostate Cancer Medicine Consumption by Countries
 6.5.2 Indonesia
 6.5.3 Thailand
 6.5.4 Singapore
 6.5.5 Malaysia
 6.5.6 Philippines
 6.6 Middle East
 6.6.1 Middle East Prostate Cancer Medicine Consumption by Countries
 6.6.2 Turkey
 6.6.3 Saudi Arabia
 6.6.4 Iran
 6.6.5 United Arab Emirates
 6.7 Africa
 6.7.1 Africa Prostate Cancer Medicine Consumption by Countries
 6.7.2 Nigeria
 6.7.3 South Africa
 6.8 Oceania
 6.8.1 Oceania Prostate Cancer Medicine Consumption by Countries
 6.8.2 Australia
 6.9 South America
 6.9.1 South America Prostate Cancer Medicine Consumption by Countries
 6.9.2 Brazil
 6.9.3 Argentina
 6.10 Rest of the World
 6.10.1 Rest of the World Prostate Cancer Medicine Consumption by Countries
 7 Global Prostate Cancer Medicine Production Forecast by Regions (2022-2027)
 7.1 Global Forecasted Production of Prostate Cancer Medicine (2022-2027)
 7.2 Global Forecasted Revenue of Prostate Cancer Medicine (2022-2027)
 7.3 Global Forecasted Price of Prostate Cancer Medicine (2022-2027)
 7.4 Global Forecasted Production of Prostate Cancer Medicine by Region (2022-2027)
 7.4.1 North America Prostate Cancer Medicine Production, Revenue Forecast (2022-2027)
 7.4.2 East Asia Prostate Cancer Medicine Production, Revenue Forecast (2022-2027)
 7.4.3 Europe Prostate Cancer Medicine Production, Revenue Forecast (2022-2027)
 7.4.4 South Asia Prostate Cancer Medicine Production, Revenue Forecast (2022-2027)
 7.4.5 Southeast Asia Prostate Cancer Medicine Production, Revenue Forecast (2022-2027)
 7.4.6 Middle East Prostate Cancer Medicine Production, Revenue Forecast (2022-2027)
 7.4.7 Africa Prostate Cancer Medicine Production, Revenue Forecast (2022-2027)
 7.4.8 Oceania Prostate Cancer Medicine Production, Revenue Forecast (2022-2027)
 7.4.9 South America Prostate Cancer Medicine Production, Revenue Forecast (2022-2027)
 7.4.10 Rest of the World Prostate Cancer Medicine Production, Revenue Forecast (2022-2027)
 7.5 Forecast by Type and by Application (2022-2027)
 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
 7.5.2 Global Forecasted Consumption of Prostate Cancer Medicine by Application (2022-2027)
 8 Global Prostate Cancer Medicine Consumption Forecast by Regions (2022-2027)
 8.1 North America Forecasted Consumption of Prostate Cancer Medicine by Country
 8.2 East Asia Market Forecasted Consumption of Prostate Cancer Medicine by Country
 8.3 Europe Market Forecasted Consumption of Prostate Cancer Medicine by Countriy
 8.4 South Asia Forecasted Consumption of Prostate Cancer Medicine by Country
 8.5 Southeast Asia Forecasted Consumption of Prostate Cancer Medicine by Country
 8.6 Middle East Forecasted Consumption of Prostate Cancer Medicine by Country
 8.7 Africa Forecasted Consumption of Prostate Cancer Medicine by Country
 8.8 Oceania Forecasted Consumption of Prostate Cancer Medicine by Country
 8.9 South America Forecasted Consumption of Prostate Cancer Medicine by Country
 8.10 Rest of the world Forecasted Consumption of Prostate Cancer Medicine by Country
 9 Global Prostate Cancer Medicine Sales by Type (2016-2027)
 9.1 Global Prostate Cancer Medicine Historic Market Size by Type (2016-2021)
 9.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2022-2027)
 10 Global Prostate Cancer Medicine Consumption by Application (2016-2027)
 10.1 Global Prostate Cancer Medicine Historic Market Size by Application (2016-2021)
 10.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2022-2027)
 11 Global Prostate Cancer Medicine Manufacturing Cost Analysis
 11.1 Prostate Cancer Medicine Key Raw Materials Analysis
 11.1.1 Key Raw Materials
 11.2 Proportion of Manufacturing Cost Structure
 11.3 Manufacturing Process Analysis of Prostate Cancer Medicine
 12 Global Prostate Cancer Medicine Marketing Channel, Distributors, Customers and Supply Chain
 12.1 Marketing Channel
 12.2 Prostate Cancer Medicine Distributors List
 12.3 Prostate Cancer Medicine Customers
 12.4 Prostate Cancer Medicine Supply Chain Analysis
 13 Analyst's Viewpoints/Conclusions
 14 Disclaimer

Add to Cart

Single User

$ 2450.00

Site License

$ 3675.00

Enterprisewide

$ 4900.00